TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study June 21, 2002
TCL Archive Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says January 29, 2010
TCL Archive Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial June 1, 2001
TCL Archive Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money April 26, 1985
TCL Archive NCI Plans to Fund FY 1985 R01s, P01s with Cuts 2.9-3.8% Under Recommended Groups, Centers Reduced 7-10% March 16, 1984
